Kalinor Retard is a hard gelatin two-piece capsule (opaque yellow capsule cap, opaque white capsule body) containing practically odourless white free-flowing pellets.
1 prolonged-release hard capsule contains 600 mg potassium chloride (potassium content 315 mg corresponds to 8 mmol = 8 mval Potassium ions).
Excipients/Inactive Ingredients: Quinoline yellow, erythrosine, ethyl cellulose, gelatin, magnesium stearate, sodium laurilsulfate, titanium dioxide.
Kalinor Retard is a mineral/potassium preparation for normalisation of the potassium balance.
Treatment of potassium deficiency conditions. Preventative use with diuretics, which lead to kaliuresis.
The dose depends on the potassium loss to be balanced and will be adapted personally for the patient. If not prescribed by a doctor, the following are the recommended doses.
For prophylaxis of a potassium deficiency in general, 2-3 capsules Kalinor Retard daily (corresponding to 16-24 mmol Potassium ions). A dosage of 3x1 capsules daily can be started, then, where necessary, adapted to the patient's personal potassium requirement.
For treatment of a potassium deficiency, 5-12 capsules Kalinor Retard daily (corresponding to 40-96 mmol Potassium ions). A dosage of 3x2 capsules daily can be started, then, where necessary, adapted to the patient's personal potassium requirement.
Method of administration: The capsules should be swallowed whole at mealtimes with plenty of fluid (at least a water glass full). If the patient has difficulties swallowing capsules, both halves of the capsule can be pulled apart and the contents taken from a spoon. Do not forget to then drink plenty of fluid (at least a water glass full).
A daily dose of more than 2 capsules should be taken divided across the day (e.g. mornings, midday, evenings), i.e. divided into 2 or more individual doses.
Duration of use: Continued administration of Kalinor Retard is recommended for as long as the cause of the potassium deficiency persists. In other cases, days to weeks often suffice to balance the potassium deficiency.
Patients should consult their doctor or pharmacist if they think that the effect of Kalinor Retard is too strong or too weak.
Forgotten intake of Kalinor Retard: Do not take a double dose to make up for a forgotten dose; however, more than 2 capsules should not be taken at once.
Stopping intake of Kalinor Retard: If Kalinor Retard should be taken to control a potassium deficiency or to prevent the occurrence of a potassium deficiency, then the intake of potassium through Kalinor Retard is necessary to maintain a balance in the potassium levels. Without taking this additional potassium, the intake of potassium through food is inadequate to cover the current potassium requirement. If patients interrupt taking Kalinor Retard or stop taking it prematurely, they may develop a potassium deficiency, which can have negative effects on the heart and the functioning of nerves and muscles.
Excess potassium is rapidly excreted by normally functioning kidneys. A harmful excessive increase in the blood potassium concentration is therefore only to be expected in the case of significant overdose. As the normal function of the heart is impaired in the case of excessively elevated blood potassium concentrations, patients should consult their doctor immediately in the case of significant overdose. The blood potassium concentration can be measured by the doctor in a laboratory test and/or the cardiac rhythm can be checked using an ECG. Where necessary, the doctor can normalise the heart function and the blood potassium concentration using suitable measures. In the case of only mildly elevated blood potassium concentration, normalisation can occur through the normal excretion of potassium via the kidneys and also without further treatment.
Kalinor Retard must not be taken if the patient is allergic to potassium chloride or any of the other ingredients of this medicine listed in Description.
Kalinor Retard must not be taken in the case of diseases that are commonly linked to hyperkalaemia: restricted excretory kidney function; dehydration; Addison's disease (primary adrenal insufficiency); adynamia episodica hereditaria (Gamstorp disease); sickle cell anaemia; metabolic imbalances in the acid region, e.g. diabetic acidosis.
Kalinor Retard must not be taken in the case of an elevated blood potassium level due to movement of potassium from the intracellular to the extracellular space, i.e. from the cells to the blood.
Particular caution is required when taking/using Kalinor Retard: The prescription of a solid potassium chloride preparation such as Kalinor Retard must be carefully considered if the patient has a known impairment of the oesophagus or the gastrointestinal tract. It may be beneficial to prescribe a potassium preparation to be taken as a liquid (e.g. as effervescent tablets) if there is a narrowing in the oesophagus, stomach or intestine for example. Other possible causes for swallowing symptoms may also be diseases that involve taking specific medicines (such as anticholinergics that work similarly to atropine from belladonna). These medicines may cause a deceleration in the further transport of a bolus as well as medicines through the stomach and intestine.
Prior to use, mineral and acid base balances (electrolyte and acid base statuses), cardiac rhythm and kidney function, particularly in elderly patients, should be checked. These values should be monitored during treatment initially in shorter intervals and later in longer intervals.
Kalinor Retard contains sodium: This drug contains less than 1 mmol sodium (23 mg) per capsule, i.e. it is almost "sodium free".
Driving and using machines: Taking Kalinor Retard has no harmful effects on the ability to drive, reaction capacity or general ability to act, even when using machines or working without secure support.
Use in Children: Kalinor Retard is not intended for use in children.
The patient should be advised before taking this medicine if she is pregnant or breast-feeding, or if she thinks she may be pregnant or is planning to have a baby.
There is no known information on harmful effects during pregnancy and lactation.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following frequency information is used when assessing undesirable effects: Very common (may affect more than 1 in 10 people); Common (may affect up to 1 in 10 people); Uncommon (may affect up to 1 in 100 people); Rare (may affect up to 1 in 1,000 people); Very rare (may affect up to 1 in 10,000 people); Not known (frequency cannot be estimated from the available data).
Possible side effects: Occasionally upper abdominal and intestinal symptoms, nausea, vomiting and diarrhoea have been observed. The occurrence of serious damage to the mucosa in the oesophageal and gastrointestinal tract region, which can be noticed as a result of severe vomiting, severe stomach pains and gastrointestinal bleeding for example, has not been observed for Kalinor Retard to date.
In addition, if patients notice side effects that are not previously listed, they should inform their doctor or pharmacist.
Taking countermeasures for side effects: Nausea and the other gastrointestinal symptoms stated previously, where they actually relate to taking Kalinor Retard, require no special treatment. To avoid them, ensure that Kalinor Retard is taken with plenty of fluid and never on an empty stomach. Information given under Dosage & Administration should be followed.
In the case of significant vomiting, severe stomach pain and gastrointestinal bleeding, patients must inform their doctor immediately and they should not take any more Kalinor Retard. The doctor will then decide what to do next.
Patients should inform their doctor or pharmacist if one of the listed side effects affects them significantly or they notice side effects that are not previously listed.
Reporting of side effects: If patients get any side effects, they should talk to their doctor, pharmacist or medical personnel. This includes any possible side effects not previously listed.
Other medicines and Kalinor Retard: Patients should be advised if they are taking/using, have recently taken/used or might take/use any other medicines.
Kalinor Retard should be used with caution in the case of simultaneous treatment with: anticholinergics; potassium-saving diuretics; aldosterone antagonists; ACE inhibitors, angiotensin II receptor blockers; medicines that may be harmful to the kidneys such as specific pain and rheumatism medicines (non-steroidal anti-inflammatories amongst others).
An interaction with the aforementioned medicines, suddenly occurring acidosis, sudden restriction of the kidney function or other conditions may lead to an incidentally occurring increase in the blood potassium concentration above the norm (hyperkalaemia). Hyperkalaemia reduces the effect of cardiac glycosides. In the case of simultaneous treatment with specific blood pressure-reducing medicines (ACE inhibitors, angiotensin II receptor blockers), aldosterone antagonists, potassium-saving diuretics or specific pain and rheumatism medicines (non-steroidal anti-inflammatories and peripheral analgesics), such as indomethacin, a special check on the blood potassium values is indicated, as the stated substances can lead to a reduction in the excretion of potassium via the kidneys and therefore an increase in the blood potassium concentration above the norm. Anticholinergics inhibit intestinal motility and therefore increase the (low) likelihood of side effects in the stomach and intestine in the case of simultaneous use. This information may also apply for medicines used recently.
Kalinor Retard with food, drink and alcohol: No interactions between taking Kalinor Retard and substances, food or drinks are to be expected.
Do not dispose of any medicines via wastewater (e.g. not using the toilet or sink). Advise patients on how to dispose of medicines no longer used. These measures will help protect the environment.
Keep container tightly closed. Store below 25°C.
Shelf life after opening: 6 months.
A12BA01 - potassium chloride ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.
Kalinor Retard PR hard cap 600 mg
100's
Sign Out
